Share-based Payment Arrangement, Expense of TransMedics Group, Inc. from 31 Mar 2018 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
TransMedics Group, Inc. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 31 Mar 2018 to 30 Sep 2025.
  • TransMedics Group, Inc. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $9,136,000, a 15% increase year-over-year.
  • TransMedics Group, Inc. Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $38,233,000, a 36% increase year-over-year.
  • TransMedics Group, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $33,224,000, a 68% increase from 2023.
  • TransMedics Group, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $19,791,000, a 92% increase from 2022.
  • TransMedics Group, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $10,321,000, a 50% increase from 2021.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

TransMedics Group, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $38,233,000 $9,136,000 +$1,192,000 +15% 01 Jul 2025 30 Sep 2025 10-Q 29 Oct 2025 2025 Q3
Q2 2025 $37,041,000 $9,372,000 +$1,729,000 +23% 01 Apr 2025 30 Jun 2025 10-Q 30 Jul 2025 2025 Q2
Q1 2025 $35,312,000 $8,958,000 +$2,088,000 +30% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $33,224,000 $10,767,000 +$5,043,000 +88% 01 Oct 2024 31 Dec 2024 10-K 27 Feb 2025 2024 FY
Q3 2024 $28,181,000 $7,944,000 +$2,756,000 +53% 01 Jul 2024 30 Sep 2024 10-Q 29 Oct 2025 2025 Q3
Q2 2024 $25,425,000 $7,643,000 +$2,685,000 +54% 01 Apr 2024 30 Jun 2024 10-Q 30 Jul 2025 2025 Q2
Q1 2024 $22,740,000 $6,870,000 +$2,949,000 +75% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025 2025 Q1
Q4 2023 $19,791,000 $5,724,000 +$2,733,000 +91% 01 Oct 2023 31 Dec 2023 10-K 27 Feb 2025 2024 FY
Q3 2023 $17,058,000 $5,188,000 +$2,484,000 +92% 01 Jul 2023 30 Sep 2023 10-Q 29 Oct 2024 2024 Q3
Q2 2023 $14,574,000 $4,958,000 +$2,642,000 +114% 01 Apr 2023 30 Jun 2023 10-Q 01 Aug 2024 2024 Q2
Q1 2023 $11,932,000 $3,921,000 +$1,611,000 +70% 01 Jan 2023 31 Mar 2023 10-Q 02 May 2024 2024 Q1
Q4 2022 $10,321,000 $2,991,000 +$1,006,000 +51% 01 Oct 2022 31 Dec 2022 10-K 27 Feb 2025 2024 FY
Q3 2022 $9,315,000 $2,704,000 +$731,000 +37% 01 Jul 2022 30 Sep 2022 10-Q 08 Nov 2023 2023 Q3
Q2 2022 $8,584,000 $2,316,000 +$508,000 +28% 01 Apr 2022 30 Jun 2022 10-Q 04 Aug 2023 2023 Q2
Q1 2022 $8,076,000 $2,310,000 +$1,198,000 +108% 01 Jan 2022 31 Mar 2022 10-Q 04 May 2023 2023 Q1
Q4 2021 $6,878,000 $1,985,000 +$1,287,000 +184% 01 Oct 2021 31 Dec 2021 10-K 27 Feb 2024 2023 FY
Q3 2021 $5,591,000 $1,973,000 +$1,273,000 +182% 01 Jul 2021 30 Sep 2021 10-Q 04 Nov 2022 2022 Q3
Q2 2021 $4,318,000 $1,808,000 +$1,177,000 +187% 01 Apr 2021 30 Jun 2021 10-Q 03 Aug 2022 2022 Q2
Q1 2021 $3,141,000 $1,112,000 +$727,000 +189% 01 Jan 2021 31 Mar 2021 10-Q 05 May 2022 2022 Q1
Q4 2020 $2,414,000 $698,000 +$416,000 +148% 01 Oct 2020 31 Dec 2020 10-K 27 Feb 2023 2022 FY
Q3 2020 $1,998,000 $700,000 +$405,000 +137% 01 Jul 2020 30 Sep 2020 10-Q 09 Nov 2021 2021 Q3
Q2 2020 $1,593,000 $631,000 +$411,000 +187% 01 Apr 2020 30 Jun 2020 10-Q 06 Aug 2021 2021 Q2
Q1 2020 $1,182,000 $385,000 +$328,000 +575% 29 Dec 2019 31 Mar 2020 10-Q 07 May 2021 2021 Q1
Q4 2019 $854,000 $282,000 +$229,000 +432% 29 Sep 2019 28 Dec 2019 10-K 11 Mar 2021 2020 FY
Q3 2019 $625,000 $295,000 +$264,000 +852% 30 Jun 2019 28 Sep 2019 10-Q 06 Nov 2020 2020 Q3
Q2 2019 $361,000 $220,000 +$187,000 +567% 31 Mar 2019 29 Jun 2019 10-Q 07 Aug 2020 2020 Q2
Q1 2019 $174,000 $57,000 +$30,000 +111% 30 Dec 2018 30 Mar 2019 10-Q 06 May 2020 2020 Q1
Q4 2018 $144,000 $53,000 30 Sep 2018 29 Dec 2018 10-K 17 Mar 2020 2019 FY
Q3 2018 $31,000 01 Jul 2018 29 Sep 2018 10-Q 08 Nov 2019 2019 Q3
Q2 2018 $33,000 01 Apr 2018 30 Jun 2018 10-Q 08 Aug 2019 2019 Q2
Q1 2018 $27,000 31 Dec 2017 31 Mar 2018 10-Q 12 Jun 2019 2019 Q1

TransMedics Group, Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $33,224,000 +$13,433,000 +68% 01 Jan 2024 31 Dec 2024 10-K 27 Feb 2025 2024 FY
2023 $19,791,000 +$9,470,000 +92% 01 Jan 2023 31 Dec 2023 10-K 27 Feb 2025 2024 FY
2022 $10,321,000 +$3,443,000 +50% 01 Jan 2022 31 Dec 2022 10-K 27 Feb 2025 2024 FY
2021 $6,878,000 +$4,464,000 +185% 01 Jan 2021 31 Dec 2021 10-K 27 Feb 2024 2023 FY
2020 $2,414,000 +$1,560,000 +183% 29 Dec 2019 31 Dec 2020 10-K 27 Feb 2023 2022 FY
2019 $854,000 +$710,000 +493% 30 Dec 2018 28 Dec 2019 10-K 11 Mar 2021 2020 FY
2018 $144,000 31 Dec 2017 29 Dec 2018 10-K 17 Mar 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.